CSX
57
6
GIS
28
2
UNP
45
6
AEE
64
4
AON
52
2
EMN
56
7
CMI
64
5
KMX
64
6
RL
68
3
STX
56
4
ADI
47
2
AEP
53
2
DHR
38
3
AVGO
22
2
RRC
59
-4
AKAM
50
7
BRK.B
42
2
ITW
62
4
EXR
60
3
KMI
69
2
CSX
57
6
GIS
28
2
UNP
45
6
AEE
64
4
AON
52
2
EMN
56
7
CMI
64
5
KMX
64
6
RL
68
3
STX
56
4
ADI
47
2
AEP
53
2
DHR
38
3
AVGO
22
2
RRC
59
-4
AKAM
50
7
BRK.B
42
2
ITW
62
4
EXR
60
3
KMI
69
2
Financhill
Back

Biomarin Pharmaceutical Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
64.22
Seasonality Move:
12.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Biomarin Pharmaceutical Price Quote

$64.22
+0.77 (+1.21%)
(Updated: November 22, 2024 at 12:50 PM ET)

Biomarin Pharmaceutical Key Stats

Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy
Day range:
$61.41 - $63.76
52-week range:
$61.15 - $99.56
Dividend yield:
0%
P/E ratio:
72.93
P/S ratio:
4.53
P/B ratio:
2.23%
Volume:
1.3M
Avg. volume:
1.5M
1-year change:
-27.95%
Market cap:
$12.1B
Revenue:
$2.4B
EPS:
$1.67

How Much Does Biomarin Pharmaceutical Make?

Is Biomarin Pharmaceutical Growing As A Company?

Biomarin Pharmaceutical Stock Price Performance

What Is Biomarin Pharmaceutical 52-Week High & Low?

Biomarin Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Biomarin Pharmaceutical?

Is Biomarin Pharmaceutical Cash Flow Positive?

  • What Is BMRN Cash Flow From Operations?
    Cash flow from operations (TTM) is $414.7M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$518.5M
  • What Is Biomarin Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.9M

Biomarin Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    BMRN return on invested capital is 5.27%
  • What Is Biomarin Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 4.69%
  • What Is BMRN Return On Equity?
    ROE is a measure of profitability and is 6.29%

Biomarin Pharmaceutical Earnings Date & Stock Price

Biomarin Pharmaceutical Competitors

Biomarin Pharmaceutical Dividend Yield

Biomarin Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 161.91% 14.73%
Revenue: 28.28% 6.03%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 98.39
Upside from Last Price: 55.06%

Major Shareholders

  • How many BMRN shares are owned by institutional investors?
    314.2M BMRN shares are owned by institutional investors
  • How many BMRN shares are owned by insiders?
    2.5M BMRN shares are owned by insiders